MicroRNAs Associated With HBV Infection And HBV-related HCC

被引:68
|
作者
Xie, Kun-Lin [1 ,2 ]
Zhang, Yan-Ge [3 ]
Liu, Jun [4 ]
Zeng, Yong [1 ,2 ]
Wu, Hong [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610041, Sichuan Provinc, Peoples R China
[2] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu 610041, Sichuan Provinc, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Burns & Plast Surg, Chengdu 610041, Sichuan Provinc, Peoples R China
[4] Sichuan Univ, West China Hosp, Dept Pharm, Chengdu 610041, Sichuan Provinc, Peoples R China
来源
THERANOSTICS | 2014年 / 4卷 / 12期
关键词
MicroRNA; Hepatitis B virus; Hepatocellular carcinoma; Diagnosis; Therapy; HEPATITIS-B-VIRUS; HUMAN HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR MICRORNA; ABERRANT DNA METHYLATION; HUMAN HEPATOMA-CELLS; LIVER-CANCER; X PROTEIN; DOWN-REGULATION; C-MET; MESENCHYMAL TRANSITION;
D O I
10.7150/thno.8715
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hepatitis B virus (HBV) infection is a global problem and a major risk factor for hepatocellular carcinoma (HCC). microRNAs (miRNAs) comprise a group of small noncoding RNAs regulating gene expression at the posttranslational level, thereby participating in fundamental biological processes, including cell proliferation, differentiation, and apoptosis. In this review, we summarize the roles of miRNAs in HBV infection, the recently identified mechanism underlying dysregulation of miRNAs in HBV-associated HCC, and their association with hepatocarcinogenesis. Moreover, we discuss the recent advances in the use of circulating miRNAs in the early diagnosis of HCC as well as therapies based on these aberrantly expressed miRNAs.
引用
收藏
页码:1176 / 1192
页数:17
相关论文
共 50 条
  • [1] Prevention of HBV-related HCC
    Liaw, Yun-Fan
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A6 - A6
  • [2] The role of sex hormones and receptors in HBV infection and development of HBV-related HCC
    Nuermaimaiti, Abudulimutailipu
    Chang, Le
    Yan, Ying
    Sun, Huizhen
    Xiao, Yingzi
    Song, Shi
    Feng, Kaihao
    Lu, Zhuoqun
    Ji, Huimin
    Wang, Lunan
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (12)
  • [3] Risk stratification for HBV-related HCC
    Kao, Jia-Horng
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 1 - 1
  • [5] Association of HBV/inflammation and sternness expression in HBV-related HCC recurrence
    Chang, Te-Sheng
    Lee, Kam-Fai
    Lin, Hsin-Yi
    Tung, Shui-Yi
    Kuo, Liang-Mou
    Jen, Xin-Wei
    Huang, Yen-Hua
    [J]. CANCER RESEARCH, 2011, 71
  • [6] Tertiary prevention of HBV-related HCC in Asia
    Wong G.L.-H.
    Chong C.-N.
    Wong V.W.-S.
    [J]. Current Hepatitis Reports, 2013, 12 (3) : 157 - 164
  • [7] HBV-related HCC, clinical issues and therapy
    Iavarone, Massimo
    Colombo, Massimo
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 : S32 - S39
  • [8] Unveiling NUSAP1 as a common gene signature linking chronic HBV infection and HBV-related HCC
    Meng, Jiao
    Yang, Zhenkun
    Jiang, Xinyi
    Zou, Jian
    [J]. DISCOVER ONCOLOGY, 2024, 15 (01)
  • [9] Excess body weight is associated with HBV-related HCC despite antiviral treatment
    Wang, Kaifeng
    Chen, Li
    Wu, Yaobo
    Zhao, Zhou
    You, Qiuhong
    Shen, Sheng
    Lin, Weiyin
    Liu, Xiaoju
    Liu, Shi
    Li, Wanying
    Deng, Rui
    Sun, Jian
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S584 - S585
  • [10] Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious
    Giri, Suprabhat
    Darak, Harish
    Kasturi, Sunil
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (10) : 4962 - 4964